<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Publications | Christian Brueffer</title><link>https://www.brueffer.io/publication/</link><atom:link href="https://www.brueffer.io/publication/index.xml" rel="self" type="application/rss+xml"/><description>Publications</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Sat, 01 Apr 2023 00:00:00 +0000</lastBuildDate><image><url>https://www.brueffer.io/media/icon_hu7422bdd1ad1d5b8840d6088d6ba7ed4c_15338_512x512_fill_lanczos_center_3.png</url><title>Publications</title><link>https://www.brueffer.io/publication/</link></image><item><title>Abstract 5710: Detection and monitoring of t(11;14) in liquid biopsies from patients with relapsed/refractory multiple myeloma treated with venetoclax-based regimens</title><link>https://www.brueffer.io/publication/2023_aacr/</link><pubDate>Sat, 01 Apr 2023 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2023_aacr/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1158/1538-7445.AM2023-5710"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1158/1538-7445.AM2023-5710"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>2022-RA-627-ESGO: Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancer</title><link>https://www.brueffer.io/publication/2022_esgo/</link><pubDate>Thu, 20 Oct 2022 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2022_esgo/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1136/ijgc-2022-ESGO.868"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1136/ijgc-2022-ESGO.868"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancer</title><link>https://www.brueffer.io/publication/2022_ovarian_cancer_ctdna/</link><pubDate>Fri, 15 Jul 2022 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2022_ovarian_cancer_ctdna/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="https://doi.org/10.21203/rs.3.rs-1770497/v1"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="https://doi.org/10.21203/rs.3.rs-1770497/v1"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions</title><link>https://www.brueffer.io/publication/2022_precisionfda/</link><pubDate>Wed, 27 Apr 2022 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2022_precisionfda/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1016/j.xgen.2022.100129"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1016/j.xgen.2022.100129"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Molecular and Serologic Diagnostic Technologies for SARS-CoV-2</title><link>https://www.brueffer.io/publication/2022_sarscov2_diagnostics/</link><pubDate>Tue, 26 Apr 2022 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2022_sarscov2_diagnostics/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.48550/arXiv.2204.12598"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.48550/arXiv.2204.12598"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Clinical associations of ESR2 (estrogen receptor beta; ERβ) expression across thousands of primary breast tumors</title><link>https://www.brueffer.io/publication/2022_scanb_esr2/</link><pubDate>Fri, 18 Mar 2022 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2022_scanb_esr2/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1038/s41598-022-08210-3"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1038/s41598-022-08210-3"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Identification and Development of Therapeutics for COVID-19</title><link>https://www.brueffer.io/publication/2021_covid19_therapeutics/</link><pubDate>Tue, 02 Nov 2021 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2021_covid19_therapeutics/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1128/mSystems.00233-21"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1128/mSystems.00233-21"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure</title><link>https://www.brueffer.io/publication/2021_covid19_pathogenesis/</link><pubDate>Tue, 26 Oct 2021 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2021_covid19_pathogenesis/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1128/mSystems.00095-21"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1128/mSystems.00095-21"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment</title><link>https://www.brueffer.io/publication/2021_covid19_neutraceuticals/</link><pubDate>Tue, 04 May 2021 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2021_covid19_neutraceuticals/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1128/mSystems.00122-21"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1128/mSystems.00122-21"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer</title><link>https://www.brueffer.io/publication/2021_scanb_esr1/</link><pubDate>Thu, 22 Apr 2021 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2021_scanb_esr1/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1093/jncics/pkab028"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1093/jncics/pkab028"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>RNA Sequencing for Molecular Diagnostics in Breast Cancer</title><link>https://www.brueffer.io/publication/2020_phd_thesis/</link><pubDate>Fri, 18 Dec 2020 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2020_phd_thesis/</guid><description/></item><item><title>The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome</title><link>https://www.brueffer.io/publication/2020_scanb_mutational_landscape/</link><pubDate>Mon, 14 Sep 2020 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2020_scanb_mutational_landscape/</guid><description>&lt;html>
&lt;head>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;/head>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.15252/emmm.202012118"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.15252/emmm.202012118"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Features of increased malignancy in eosinophilic clear cell renal cell carcinoma</title><link>https://www.brueffer.io/publication/2020_eosinophilic_ccrcc/</link><pubDate>Thu, 20 Aug 2020 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2020_eosinophilic_ccrcc/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1002/path.5532"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1002/path.5532"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival</title><link>https://www.brueffer.io/publication/2020_aacr/</link><pubDate>Sat, 15 Aug 2020 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2020_aacr/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1158/1538-7445.AM2020-CT074"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1158/1538-7445.AM2020-CT074"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>A crowdsourced set of curated structural variants for the human genome</title><link>https://www.brueffer.io/publication/2020_giab_sv_curation/</link><pubDate>Fri, 19 Jun 2020 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2020_giab_sv_curation/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1371/journal.pcbi.1007933"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1371/journal.pcbi.1007933"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).</title><link>https://www.brueffer.io/publication/2020_asco/</link><pubDate>Mon, 25 May 2020 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2020_asco/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1200/JCO.2020.38.15_suppl.518"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1200/JCO.2020.38.15_suppl.518"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Plasma circulating tumor DNA as a genomic biomarker for ovarian cancer</title><link>https://www.brueffer.io/publication/2019_ehgc/</link><pubDate>Tue, 01 Oct 2019 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2019_ehgc/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi=""
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi=""
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment</title><link>https://www.brueffer.io/publication/2019_fornvik_ctdna_vs_ctc_after_breast_compression/</link><pubDate>Mon, 01 Jul 2019 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2019_fornvik_ctdna_vs_ctc_after_breast_compression/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1007/s10549-019-05326-5"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1007/s10549-019-05326-5"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Bioconda: sustainable and comprehensive software distribution for the life sciences</title><link>https://www.brueffer.io/publication/2018_bioconda/</link><pubDate>Mon, 02 Jul 2018 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2018_bioconda/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1038/s41592-018-0046-7"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1038/s41592-018-0046-7"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network–Breast Initiative</title><link>https://www.brueffer.io/publication/2018_scan-b_biomarker_prediction/</link><pubDate>Thu, 01 Mar 2018 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2018_scan-b_biomarker_prediction/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1200/PO.17.00135"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1200/PO.17.00135"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B</title><link>https://www.brueffer.io/publication/2018_sabcs_subtypes/</link><pubDate>Thu, 15 Feb 2018 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2018_sabcs_subtypes/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1158/1538-7445.SABCS17-P2-02-09"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1158/1538-7445.SABCS17-P2-02-09"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study</title><link>https://www.brueffer.io/publication/2018_sabcs_classifiers/</link><pubDate>Thu, 15 Feb 2018 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2018_sabcs_classifiers/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1158/1538-7445.SABCS17-P4-09-03"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1158/1538-7445.SABCS17-P4-09-03"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>TopHat-Recondition: A post-processor for TopHat unmapped reads</title><link>https://www.brueffer.io/publication/2016_tophat-recondition/</link><pubDate>Wed, 04 May 2016 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2016_tophat-recondition/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1186/s12859-016-1058-x"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1186/s12859-016-1058-x"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing</title><link>https://www.brueffer.io/publication/2015_primary_met_bc/</link><pubDate>Fri, 02 Oct 2015 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2015_primary_met_bc/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.18632/oncotarget.5951"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.18632/oncotarget.5951"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing</title><link>https://www.brueffer.io/publication/2015_contralateral_bc/</link><pubDate>Wed, 05 Aug 2015 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2015_contralateral_bc/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1186/s13058-015-0608-x"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1186/s13058-015-0608-x"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>Abstract 4805: Whole genome sequencing of primary breast cancers and matched distant metastases</title><link>https://www.brueffer.io/publication/2015_aacr/</link><pubDate>Sat, 01 Aug 2015 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2015_aacr/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1158/1538-7445.AM2015-4805"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1158/1538-7445.AM2015-4805"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>The Sweden Cancerome Analysis Network-Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine</title><link>https://www.brueffer.io/publication/2015_scan-b_pop/</link><pubDate>Mon, 02 Feb 2015 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2015_scan-b_pop/</guid><description>&lt;html>
&lt;style>
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
&lt;/style>
&lt;section>
&lt;div id="inner">
&lt;script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'>&lt;/script>
&lt;span style="float:left";
class="__dimensions_badge_embed__"
data-doi="10.1186/s13073-015-0131-9"
data-hide-zero-citations="true"
data-legend="always">
&lt;/span>
&lt;script async src="https://badge.dimensions.ai/badge.js" charset="utf-8">&lt;/script>
&lt;div style="float:right";
data-link-target="_blank"
data-badge-details="right"
data-badge-type="medium-donut"
data-doi="10.1186/s13073-015-0131-9"
data-condensed="true"
data-hide-no-mentions="true"
class="altmetric-embed">
&lt;/div>
&lt;/div>
&lt;/section></description></item><item><title>FreeBSD Security Event Auditing</title><link>https://www.brueffer.io/publication/2009_bsd_magazine_auditing/</link><pubDate>Wed, 01 Apr 2009 00:00:00 +0000</pubDate><guid>https://www.brueffer.io/publication/2009_bsd_magazine_auditing/</guid><description/></item></channel></rss>